Type 1 diabetes mellitus (T1DM) results from autoimmune destruction of pancreatic β-cells, resulting in absolute insulin deficiency, necessitating exogenous insulin therapy for glycaemic control. Here, INS is linked to type 1 diabetes mellitus.